These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3092307)
1. Effect of intravenous immunoglobulin G on neutrophil kinetics during experimental group B streptococcal infection in neonatal rats. Harper TE; Christensen RD; Rothstein G; Hill HR Rev Infect Dis; 1986; 8 Suppl 4():S401-8. PubMed ID: 3092307 [TBL] [Abstract][Full Text] [Related]
2. The effect of hybridoma antibody administration upon neutrophil kinetics during experimental type III group B streptococcal sepsis. Christensen RD; Rothstein G; Hill HR; Pincus SH Pediatr Res; 1983 Oct; 17(10):795-9. PubMed ID: 6356000 [TBL] [Abstract][Full Text] [Related]
3. Survival and neutrophil kinetics in infants with severe group B streptococcal disease treated with gamma globulin. Friedman CA; Robbins KK; Temple DM; Miller CJ; Rawson JE J Perinatol; 1996; 16(6):439-42. PubMed ID: 8979181 [TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental group B streptococcal infection with hybridoma antibody. Christensen RD; Rothstein G; Hill HR; Pincus SH Pediatr Res; 1984 Nov; 18(11):1093-6. PubMed ID: 6393022 [TBL] [Abstract][Full Text] [Related]
6. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. Christensen RD; Brown MS; Hall DC; Lassiter HA; Hill HR J Pediatr; 1991 Apr; 118(4 Pt 1):606-14. PubMed ID: 1901083 [TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats. Iguchi K; Inoue S; Kumar A Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109 [TBL] [Abstract][Full Text] [Related]
8. Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis. Christensen RD; Shigeoka AO; Hill HR; Rothstein G Pediatr Res; 1980 Jun; 14(6):806-8. PubMed ID: 6995919 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans. Fischer GW; Weisman LB; Hemming VG; London WT; Hunter KW; Bosworth JM; Sever JL; Wilson SR; Curfman BL Am J Med; 1984 Mar; 76(3A):117-23. PubMed ID: 6424443 [TBL] [Abstract][Full Text] [Related]
10. Polyvalent group B streptococcal immune globulin for intravenous administration: overview. Fischer GW; Hemming VG; Gloser HP; Bachmayer H; von Pilar CE; Wilson SR; Baron PA Rev Infect Dis; 1990; 12 Suppl 4():S483-9; discussion S489-91. PubMed ID: 2194273 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Cairo MS; Mauss D; Kommareddy S; Norris K; van de Ven C; Modanlou H Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023 [TBL] [Abstract][Full Text] [Related]
12. Neutrophil mobilization induced by complement fragments during experimental group B streptococcal (GBS) infection. Shigeoka AO; Gobel RJ; Janatova J; Hill HR Am J Pathol; 1988 Dec; 133(3):623-9. PubMed ID: 3059808 [TBL] [Abstract][Full Text] [Related]
13. High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats. Weisman LE; Lorenzetti PM J Pediatr; 1989 Sep; 115(3):445-50. PubMed ID: 2671331 [TBL] [Abstract][Full Text] [Related]
14. Type-specific monoclonal antibody enhances the local phagocytic response to group B streptococcal infection. Shigeoka AO; Weber ME; Pincus SH; Pritchard DG; Egan ML; Hill HR J Infect Dis; 1986 Jun; 153(6):1170-3. PubMed ID: 3517190 [No Abstract] [Full Text] [Related]
15. Granulocyte transfusions in septic adult and newborn rats: distribution of granulocytes and effect on peripheral blood and bone marrow. Baley JE; Bruce M; Stork EK; Klinger JD; Medvik K; Shurin S J Lab Clin Med; 1990 Mar; 115(3):283-91. PubMed ID: 2313160 [TBL] [Abstract][Full Text] [Related]
16. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci. Fischer GW; Wilson SR; Hunter KW J Clin Immunol; 1982 Apr; 2(2 Suppl):31S-35S. PubMed ID: 7045156 [TBL] [Abstract][Full Text] [Related]
17. Functional activities of various preparations of human intravenous immunoglobulin against type III group B Streptococcus. Kim KS; Wass CA; Kang JH; Anthony BF J Infect Dis; 1986 Jun; 153(6):1092-7. PubMed ID: 3517187 [TBL] [Abstract][Full Text] [Related]
18. Intravenous gamma globulin as adjunct therapy for severe group B streptococcal disease in the newborn. Friedman CA; Wender DF; Temple DM; Rawson JE Am J Perinatol; 1990 Jan; 7(1):1-4. PubMed ID: 2104748 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of phagocyte response to group B streptococcal infections in newborn rats. Schuit KE; DeBiasio R Infect Immun; 1980 May; 28(2):319-24. PubMed ID: 6995304 [TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus. Shigeoka AO; Pincus SH; Rote NS; Hill HR J Infect Dis; 1984 Mar; 149(3):363-72. PubMed ID: 6371154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]